Patrick Burch
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 7
- Lung Cancer Research Studies 2
- Cancer Immunotherapy and Biomarkers 2
-
- Cancer therapeutics and mechanisms 2
- Polyamine Metabolism and Applications 1
- Co-authors
- Shepard M. Zedaker (1 shared paper)Stanimir Vuk‐Pavlović (2 shared papers)Ronald L. Richardson (2 shared papers)Frank H. Valone (2 shared papers)Dennis A. Gastineau (2 shared papers)Henry C. Pitot (3 shared papers)Gary A. Croghan (1 shared paper)Lori Jones (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)The Prostate (1 paper)Journal of Neuro-Oncology (1 paper)Mayo Clinic Proceedings (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United States
In The Last Decade
Patrick Burch
13 papers receiving 618 citations
Peers
Comparison fields: 5 of 75
- Immunology 307
- Oncology 318
- Pulmonary and Respiratory Medicine 174
- Nature and Landscape Conservation 49
- Molecular Biology 249
Countries citing papers authored by Patrick Burch
This map shows the geographic impact of Patrick Burch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Burch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Burch more than expected).
Fields of papers citing papers by Patrick Burch
This network shows the impact of papers produced by Patrick Burch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Burch. The network helps show where Patrick Burch may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Burch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer. | 2000 | 222 |
| 2 | 2004 | 156 | |
| 3 | 1998 | 95 | |
| 4 | 2003 | 66 | |
| 5 | Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy. | 2000 | 65 |
| 6 | 1996 | 15 | |
| 7 | 1998 | 11 | |
| 8 | 1994 | 7 | |
| 9 | 2001 | 7 | |
| 10 | 2015 | 4 | |
| 11 | 2011 | 3 | |
| 12 | 2011 | 1 | |
| 13 | 2004 | 1 |
About Patrick Burch
Patrick Burch is a scholar working on Oncology, Molecular Biology, Nature and Landscape Conservation, Immunology and Plant Science, having authored 13 papers that have together received 653 indexed citations. Recurring topics across this work include Seedling growth and survival studies (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer therapeutics and mechanisms (2 papers), Plant Physiology and Cultivation Studies (2 papers), Lung Cancer Research Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Polyamine Metabolism and Applications (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Immunology (307 citations), Oncology (318 citations), Pulmonary and Respiratory Medicine (174 citations), Nature and Landscape Conservation (49 citations) and Molecular Biology (249 citations). Patrick Burch has collaborated with scholars based in United States. Frequent co-authors include Shepard M. Zedaker, Stanimir Vuk‐Pavlović, Ronald L. Richardson, Frank H. Valone, Dennis A. Gastineau, Henry C. Pitot, Gary A. Croghan, Lori Jones, Jan C. Buckner and Jelle W. Kylstra. Their work appears in journals such as Journal of Clinical Oncology, The Prostate, Journal of Neuro-Oncology, Mayo Clinic Proceedings and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.